Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01HL126827)
Article History
Accepted: 9 August 2021
First Online: 29 October 2021
Declarations
:
: Dr. Tang is a consultant for Sequana Medical A.G., Owkin Inc., PreCARDIA Inc., Relypsa Inc., Genomics plc, and Cardiol Therapeutics Inc. and has received honorarium from Springer Nature for authorship/editorship and American Board of Internal Medicine for exam writing committee participation, all unrelated to the contents of this paper. All other authors have no relationships to disclose.